Published 07/17/2024 10:19:15 a.m.

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics? - Viking Therapeutics (NASDAQ:VKTX), Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY), Structure Therapeutics

Summary by Benzinga

Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Viking Therapeutics Inc (NASDAQ:VKTX), and Structure Therapeutics Inc (NASDAQ:GPCR) stocks are trading lower on Wednesday. What happened? Earlier on Wednesday, Roche Holdings AG (OTC:RHHBY) announced topline results from two arms of an ongoing multi-part Phase 1 clinical trial for CT-996 for type 2 diabetes and obesity. The data showed that treatment with CT-996 in participants with obesi…

0 Articles

All

Left

Center

Right

CNBC

Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche

Novo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche's latest obesity drug candidate.

07/17/2024 10:19:15 a.m.·United States

Read Full Article

Benzinga

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics? - Viking Therapeutics (NASDAQ:VKTX), Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY), Structure Therapeutics

07/17/2024 2:47:40 p.m.·New York, United States

Read Full Article

MarketWatch

Roche obesity-pill trial results weigh on shares of Eli Lilly, Novo Nordisk

Shares of weight-loss drugmakers including Eli Lilly, Novo Nordisk and Structure Therapeutics fell on Wednesday after Roche Holding announced positive early-stage trial data for its experimental obesity pill.

07/17/2024 4:54:00 p.m.·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year